East and Central African Journal of Pharmaceutical Sciences https://www.ajol.info/index.php/ecajps <p><em>The East and Central African Journal of Pharmaceutical Sciences</em> is dedicated to all aspects of Pharmaceutical Sciences research and is published in English.</p><p>The scientific papers published in the Journal fall into three main categories: review papers, original research papers and short communications. Review papers in any discipline of pharmaceutical sciences are written at the invitation of the editor. They may cover highly specialized fields or general subjects of importance. Original research papers and short communications should describe original and unpublished work. The main purpose of short communications is rapid communication of brief (and often preliminary) research results on current topical issues. They should be limited to one or two double-spaced written pages. Original research papers are subjected to external review, whereas short communications may sometimes only be reviewed by the receiving editor.<br />The journal also covers announcements and reports on symposia, meetings, courses and other events of interest as well as book reviews and new literature surveys in pharmaceutical and allied sciences.</p><p>Other websites associated with this journal: <a title="http://uonjournals.uonbi.ac.ke/ojs/index.php/ecajps/i" href="http://uonjournals.uonbi.ac.ke/ojs/index.php/ecajps/issue/archive" target="_blank">http://uonjournals.uonbi.ac.ke/ojs/index.php/ecajps/i</a></p> en-US Copyright for articles published in this journal is retained by the journal. ecajps@uonbi.ac.ke (Prof CK Maitai) peter.njogu@uonbi.ac.ke (Peter Njogu) Wed, 10 Jan 2024 09:34:43 +0000 OJS 3.3.0.11 http://blogs.law.harvard.edu/tech/rss 60 Editorial: Strengthening the Local Pharmaceutical Industry: A Vital Pillar of Universal Health Coverage https://www.ajol.info/index.php/ecajps/article/view/262149 <p>No Abstract</p> Kennedy O. Abuga Copyright (c) 2024 https://www.ajol.info/index.php/ecajps/article/view/262149 Wed, 10 Jan 2024 00:00:00 +0000 Alcohol-Based Hand Sanitizers: Relevance of the Physicochemical Properties of Alcohol-Water Mixtures https://www.ajol.info/index.php/ecajps/article/view/262151 <p>The use of alcohol-water mixtures as antimicrobial agents for hand-hygiene grew significantly in the year 2020 due to the global&nbsp; COVID-19 pandemic. Combining alcohols, such as ethanol or isopropanol, with water results in mixtures with a number of unusual characteristics with several solution properties deviating from ideal behavior. These characteristics are related to clustering or&nbsp; aggregation of the constituent molecules at the microscopic level. This paper reviews the physicochemical properties (polarity, density, viscosity, vapor pressure, surface tension) of alcohol-water mixtures and their relevance to alcohol-based hand sanitizers. The role of the&nbsp; quasi-surfactant characteristics (amphiphilism, surface and interfacial tension lowering) of alcohols in eliciting their antimicrobial effects&nbsp; is discussed.</p> Nasser N. Nyamweya , Kennedy O. Abuga Copyright (c) 2024 https://www.ajol.info/index.php/ecajps/article/view/262151 Wed, 10 Jan 2024 00:00:00 +0000 A retrospective study of oral and dermatological formulations compounded via dosage form modifications at Kenyatta National Hospital from January 2020 to December 2021 https://www.ajol.info/index.php/ecajps/article/view/262153 <p>The current study aimed to elucidate the extent of compounding involving dosage form modifications at Kenyatta National hospital from&nbsp; 2020-2021. A total of 2205 oral formulations, containing one out of thirty-eight active pharmaceutical ingredients, were compounded&nbsp; from commercially available tablets or capsules during the study period. The most frequently compounded oral formulations were&nbsp; furosemide (34.40%), spironolactone (25.72%), and sildenafil (9.40%) suspensions, which also accounted for the highest volumes produced. The study revealed that the total volume of oral formulations compounded was 161.4L, a marked rise from 38.4L compounded&nbsp; in the 2012-2013 period. Oral formulations were all prepared using 40% dextrose as diluent, packaged in amber colored plastic bottles and recommended for storage at 4-8°C. The majority of the formulations (71.29%) were assigned a beyond-use date of 14 days, in&nbsp; compliance to the United States Pharmacopeia (USP)recommendation. A total of 17 dermatological formulations, comprising either&nbsp; singleentity or dual combination of three active pharmaceutical ingredients, were prepared from commercially available powders or&nbsp; tablets during the two-year study period. The dermatologicals were reformulated as either ointments (with emulsifying ointment as&nbsp; diluent) or pastes (with white soft paraffin as base), packaged in white translucent plastic jars and recommended for storage at room&nbsp; temperature. Nifedipine paste accounted for the highest percentage by weight and frequency of the dermatological formulations. About&nbsp; 75.76% of the dermatological formulation were assigned a beyond-use date of 30 days, in compliance with the USP recommendation. The&nbsp; study revealed that extensive compounding, involving dosage form modifications, was carried out during the study period.&nbsp;</p> Sharon W. Wanyeki , Lucy J. Tirop Copyright (c) 2024 https://www.ajol.info/index.php/ecajps/article/view/262153 Wed, 10 Jan 2024 00:00:00 +0000 Formulation design and <i>in vitro</i> characterization of gastroretentive floating acyclovir tablets https://www.ajol.info/index.php/ecajps/article/view/262154 <p>Acyclovir is a thymidine kinase enzyme inhibitor used in the management of herpes zoster. Doses above 400mg exhibit poor&nbsp; bioavailability necessitating frequent administration to achieve the required therapeutic serum concentrations. This study aimed to&nbsp; design, formulate, and characterize floating tablets with enhanced bioavailability due to improved gastric retention time. The simplex&nbsp; lattice mixture design was employed to guide polymer proportions. Independent variables included polymers HPMC K100M, HPMC K4M,&nbsp; and Carbopol. The dependent variables were the floating lag time, total floating time and the cumulative drug release at 3, 6, and 8 hours, respectively. Formulation F2 exhibited the most desirable profile with a floating lag time and total floating time of 142 seconds and&nbsp; 14 hours, respectively and cumulative drug release at 3, 6, and 8 hours of 38.3%, 66.0% and 81.2 %, respectively. The findings indicate&nbsp; the feasibility of fabricating a commercially viable floating acyclovir tablet exhibiting extended gastric retention time and a&nbsp; controlled drug release profile.</p> Geoffrey Kiriiri, Lucy Tirop, Shital Maru, Dennis Ongarora, Alex Mwangi , Agnes Mathenge Copyright (c) 2024 https://www.ajol.info/index.php/ecajps/article/view/262154 Wed, 10 Jan 2024 00:00:00 +0000 Quality Assessment of Eucalyptus Oils Available in Nairobi County, Kenya https://www.ajol.info/index.php/ecajps/article/view/262156 <p>This study assessed eucalyptus oil quality in Nairobi County, Kenya, a product that garnered global attention during the COVID-19&nbsp; pandemic. Twelve Eucalyptus oil product samples were obtained from local retailers encompassing community pharmacies,&nbsp; supermarkets and health shops. Gas chromatography was utilized for the identification and assay of the primary component, Eucalyptol.&nbsp; Additionally, an evaluation of product attributes, including optical rotation, refractive index, and relative density, was performed on the&nbsp; samples. The examination also extended to product labels and packaging to ensure conformity with established standards. Seven&nbsp; samples adhered to the stipulated labelling and packaging criteria, while two failed the refractive index test, and nine did not meet the&nbsp; relative density specifications. All samples met the optical rotation acceptance criteria. Only one sample conformed to the prescribed&nbsp; content specifications. These findings shed light on the quality of eucalyptus oils and have public health and regulatory implications,&nbsp;&nbsp; particularly given their increased use during the COVID-19 pandemic.</p> Faith Chelangat, Peggoty Mutai, Alex Okaru, Obed Kingondu , Raphael Ingwela Copyright (c) 2024 https://www.ajol.info/index.php/ecajps/article/view/262156 Wed, 10 Jan 2024 00:00:00 +0000